Page 5 - Weight Loss

Why Ozempic maker Novo Nordisk is losing its lead in weight-loss drugs

The Danish drugmaker led the obesity revolution with Ozempic and Wegovy but now lags Eli Lilly in efficacy, trials, and strategy in a $150-bn market

Novo Nordisk to launch weight-loss drug Wegovy in India ahead of schedule

Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in the Indian market

Ozempic teeth, face and tongue: Side effects of GLP-1 drugs explained

As the use of weight-loss injections rises, users report effects like Ozempic face, tongue, and teeth- here is what these mean and how to manage them

What happens to your weight after stopping Ozempic, Wegovy or Mounjaro?

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping- experts explain why it happens, who's at risk, and how to keep the weight off

Eli Lilly's tirzepatide shows superior weight loss to Novo's semaglutide

Phase 3b trial finds Lilly's tirzepatide delivers higher average weight loss and waist reduction than Novo's semaglutide in people with obesity or overweight

Mounjaro helps users lose more weight than Wegovy, new trial reveals

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress on Obesity comparing new-generation weight-loss drugs

Can weight-loss drugs like Ozempic help prevent cancer? New study says yes

New research suggests GLP-1 drugs like Ozempic, Wegovy, Mounjaro may lower the risk of several obesity-related cancers, even matching surgery in preventive benefits

US judge denies injunction, restricts copies of weight-loss drug Ozempic

A US judge earlier barred compounders from making copies of Eli Lilly's Zepbound and Mounjaro

Eli Lilly's first weight-loss pill shows success in initial Phase 3 trials

Lilly CEO says if approved, drug could be manufactured and launched at scale globally

Why Mounjaro's India entry has doctors and patients picking up the phone

With obesity on the rise, Eli Lilly's weight-loss injection triggers a rush of consultations as Indians seek safer, cheaper options to black-market drugs

Kapil Sharma stuns internet with sleek new look ahead of film sequel

Kapil Sharma, who is gearing up for the sequel to Kis Kisko Pyaar Karoon, left fans stunned with his dramatic weight loss. Social media is abuzz, calling it the 'best example of hard work'

Mumbai-based start-up launches probiotic combo for weight management

Co claims that the formulation naturally increases GLP-1 levels and regulates appetite

Weight-loss drug Mounjaro now available in India: All you need to know

Mounjaro, Eli Lilly's diabetes and obesity drug, is now available in India at a fraction of its US price. It offers treatment for weight loss and diabetes control, but watch out for the side effects

Herbalife faces challenge from homegrown Modiway in weight-loss mkt

To put into perspective, the weight-loss market is big and, according to industry estimates, it hit $25 billion in 2024, and is expected to expand to $55 billion by 2033

Harsh Goenka pokes fun at morning ritual of drinking warm honey-lemon water

According to his X post, billionaire Harsh Goenka tried the popular 'weight-loss' drink of warm honey-lemon water but it did not work out as planned

In weight loss battle, Novo and Lilly face offensive from licenced copies

Since Novo's blockbuster Ozempic diabetes treatment was approved in the United States in 2017, regulators have greenlighted 22 medicines containing its main ingredient in Bangladesh, Laos, Russia

Eli Lilly's weight-loss, diabetes drug shortage is resolved, says US FDA

The finding effectively bars widespread sales of cheaper copies of the drugs that many patients use, but the FDA said it would not take any action against the compounding pharmacies

Novo Nordisk India execs urge early Wegovy launch as rival Eli Lilly looms

Novo and Lilly are both scaling up production as they vie for a dominant share of a weight-loss market that some analysts forecast could reach $150 billion a year in the next decade

Hims & Hers Health plans to offer generic version of Novo Nordisk's drug

Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication kits at $79 per month

Novo's new obesity drug, Wegovy in race to becoming top selling franchise

The Danish drugmaker's arch-rival Eli Lilly & Co. has introduced another shot - Zepbound, also known as Mounjaro - that so far has shown even more weight loss than Wegovy